In vitro and in vivo efficacy of the Active Oligo Skin complex™, a new active ingredient processed from seawater, on multiple parameters of atopic skin.

Q3 Medicine
Skin health and disease Pub Date : 2025-02-14 eCollection Date: 2025-02-01 DOI:10.1093/skinhd/vzae029
Nicolas Lebonvallet, Chloé Catovic, Marc Feuilloley, Raphael Leschiera, Alexia Reux, Matthieu Talagas, Ianis Cousin, Laurent Misery, Emilie Simon, Sylvie Chopin, Johan Gardères
{"title":"<i>In vitro</i> and <i>in vivo</i> efficacy of the Active Oligo Skin complex™, a new active ingredient processed from seawater, on multiple parameters of atopic skin.","authors":"Nicolas Lebonvallet, Chloé Catovic, Marc Feuilloley, Raphael Leschiera, Alexia Reux, Matthieu Talagas, Ianis Cousin, Laurent Misery, Emilie Simon, Sylvie Chopin, Johan Gardères","doi":"10.1093/skinhd/vzae029","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Different symptoms are associated with atopic skin, including dryness, pruritus and pain, and affect patients' quality of life. The environment, microbiota, epidermis, immune and nerve cells are all implicated in the pathogenesis of atopic skin. <i>Staphylococcus aureus</i> is the focus of particular attention. Epidermis is implicated at multiple levels: inflammatory process, barrier, control of moisture and water loss. Sensory neurons that participate in cutaneous neurogenic inflammation and pruritus are seen as a potential new target. Specific management strategies and new treatments for adults and children are needed to help in more refractory cases. As a baseline of management, guidelines recommend a treatment to moisturize the skin and maintain the skin barrier function, such as an emollient.</p><p><strong>Objectives: </strong>To evaluate a new product <i>in vitro</i> and <i>in vivo</i> in order to validate the potential of its use in people with atopic skin or dry skin.</p><p><strong>Methods: </strong>A specific mineral composition, Active Oligo Skin complex™, from seawater was developed and included in a balm. The effects of a solution and balm containing the complex were evaluated <i>in vitro</i> on the growth and biofilm formation of <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i> in different skin models, and <i>in vivo</i> in adult and young volunteers.</p><p><strong>Results: </strong><i>In vitro</i>, the complex modulated bacterial biofilm formation and growth, decreased cytokine [interleukin (IL)-1, IL-6, IL-4] and neuropeptide (substance P) release, and increased the expression of CL1 and CL4. On volunteers with dry skin, the complex had a moisturizing effect after 1 h of application. Dryness and roughness were also reduced in young participants with atopic skin. The balm decreased erythema and pruritus after 21 days of topical application on 60 young participants. On 22 adult participants, stinging score was decreased after -application.</p><p><strong>Conclusions: </strong>The Active Oligo Skin complex™ appears to display potent antipruritic and anti-inflammatory activities, both <i>in vitro</i> and <i>in vivo</i>.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 1","pages":"22-30"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11924379/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Skin health and disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/skinhd/vzae029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Different symptoms are associated with atopic skin, including dryness, pruritus and pain, and affect patients' quality of life. The environment, microbiota, epidermis, immune and nerve cells are all implicated in the pathogenesis of atopic skin. Staphylococcus aureus is the focus of particular attention. Epidermis is implicated at multiple levels: inflammatory process, barrier, control of moisture and water loss. Sensory neurons that participate in cutaneous neurogenic inflammation and pruritus are seen as a potential new target. Specific management strategies and new treatments for adults and children are needed to help in more refractory cases. As a baseline of management, guidelines recommend a treatment to moisturize the skin and maintain the skin barrier function, such as an emollient.

Objectives: To evaluate a new product in vitro and in vivo in order to validate the potential of its use in people with atopic skin or dry skin.

Methods: A specific mineral composition, Active Oligo Skin complex™, from seawater was developed and included in a balm. The effects of a solution and balm containing the complex were evaluated in vitro on the growth and biofilm formation of Staphylococcus aureus and Staphylococcus epidermidis in different skin models, and in vivo in adult and young volunteers.

Results: In vitro, the complex modulated bacterial biofilm formation and growth, decreased cytokine [interleukin (IL)-1, IL-6, IL-4] and neuropeptide (substance P) release, and increased the expression of CL1 and CL4. On volunteers with dry skin, the complex had a moisturizing effect after 1 h of application. Dryness and roughness were also reduced in young participants with atopic skin. The balm decreased erythema and pruritus after 21 days of topical application on 60 young participants. On 22 adult participants, stinging score was decreased after -application.

Conclusions: The Active Oligo Skin complex™ appears to display potent antipruritic and anti-inflammatory activities, both in vitro and in vivo.

Active Oligo Skin complex™是一种从海水中提取的新型活性成分,它对特应性皮肤的多种参数的体外和体内疗效。
背景:特应性皮肤的干燥、瘙痒、疼痛等不同症状影响患者的生活质量。环境、微生物群、表皮、免疫细胞和神经细胞都与特应性皮肤的发病机制有关。金黄色葡萄球菌是特别关注的焦点。表皮涉及多个层面:炎症过程、屏障、控制水分和水分流失。参与皮肤神经源性炎症和瘙痒的感觉神经元被视为潜在的新靶点。需要针对成人和儿童的具体管理策略和新的治疗方法来帮助治疗更多的难治性病例。作为管理的基线,指南建议使用润肤剂等治疗方法来滋润皮肤并保持皮肤屏障功能。目的:在体外和体内评估一种新产品,以验证其在特应性皮肤或干性皮肤患者中的应用潜力。方法:从海水中提取一种特殊的矿物成分,Active Oligo Skin complex™,并将其包含在软膏中。研究了含该复合物的溶液和软膏在体外对不同皮肤模型中金黄色葡萄球菌和表皮葡萄球菌生长和生物膜形成的影响,以及在体内对成人和年轻志愿者的影响。结果:在体外,该复合物可调节细菌生物膜的形成和生长,降低细胞因子[白细胞介素(IL)-1、IL-6、IL-4]和神经肽(P物质)的释放,增加CL1、CL4的表达。对于皮肤干燥的志愿者,该复合物在使用1小时后具有保湿效果。患有特应性皮肤的年轻参与者的干燥和粗糙程度也有所降低。在60名年轻参与者局部应用21天后,这种软膏减少了红斑和瘙痒。对22名成人受试者,施药后刺痛评分降低。结论:Active Oligo Skin复合物™在体外和体内均显示出有效的止痒和抗炎活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
0
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信